CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
Live CME Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Microbiome targeting with nicotinic acid may improve insulin sensitivity in obesity
TPIAT benefits some patients with chronic pancreatitis
Children with liver transplants often don't stick to their meds
New scoring model may predict liver graft failure after transplant
Special Report-In a hospital ward in Yemen, the collapse of a nation
View Complete News Library
March 10-14
AATOD - American Association for the Treatment of Opioid Dependence
New York, NY, USA
March 14-18
APASL - Asian Pacific Association for the Study of Liver
New Delhi, Delhi, India
March 24-25
GALA - GI & Liver Association of the Americas
Dallas, TX, USA
April 11-15
EASL - European Association for the Study of the Liver
Paris, France
April 12-15
ASAM - American Society of Addiction Medicine
San Diego, CA, USA
View all Congresses
  Featured Abstracts          
Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C
Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world
Hepatitis C and Human Immunodeficiency Virus Co-Infection in the Era of Direct-Acting Antiviral Agents: No Longer A Difficult to Treat Population
The influence of immunosuppressants on direct-acting antiviral therapy is dependent on hepatitis C virus genotype
Increasing Prevalence of Hepatitis C among Hospitalized Children Is Associated with an Increase in Substance Abuse
Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing
Diagnostic accuracy of tests to detect hepatitis B surface antigen: a systematic review of the literature and meta-analysis
Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses
Vaccinations in Older Adults
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy
A Risk Score to Predict the Development of Hepatic Encephalopathy in a Population-Based Cohort of Patients with Cirrhosis
The impact of rifaximin-? on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
Recent advances in hepatic encephalopathy
Treatment options after sorafenib failure in patients with hepatocellular carcinoma
Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma
Diabetes, Metabolic Comorbidities and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: role of the treatment regimen
          View All Abstracts  
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Sponsors & Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Substance Use Disorder
CLDF Follow Us
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2018 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.